Vividion Therapeutics
The Principal Scientist, Chemical Development will develop robust synthetic processes and deliver non-GMP and GMP material on a multi-kilogram scale. This role involves leading external scientists, managing CDMO partners, and implementing strategies to progress compounds from preclinical development through proof-of-concept. The position requires cross-functional collaboration to support preclinical and clinical needs for small molecule programs.
We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with devastating diseases not
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vividion Therapeutics.
27% above the average for this role
Principal Scientist
BioLife Plasma Services
Director, Chemical Development
Cytokinetics
Research Scientist III; Chemical Development
Curia
Senior Scientist
BioLife Plasma Services
Principal Scientist of Oligonucleotide Development
Dyne Therapeutics
Associate Director, CMC Synthetic Chemistry – Small Molecule
Beeline Medicines